Prof. of Biruni University, Faculty of Pharmacy, Turkey
Ismail Tuncer DEGIM 🎓, born on 17 February 1963, is a distinguished professor in pharmaceutical sciences with a robust educational background, including a Ph.D. from the University of Wales, Cardiff. His career at Gazi University and Biruni University has seen him rise from Research Assistant to Dean 👨🏫. With numerous patents to his name, including innovations in drug delivery systems 💊, Dr. DEGIM has significantly impacted community health. His leadership roles, editorial board memberships 📚, and consultancy for Turkey’s Health Ministry underscore his commitment to advancing pharmaceutical research and education. His work not only enhances scientific understanding but also brings practical healthcare solutions to communities, making him a deserving candidate for the Research for Community Impact Award 🏆.
Professional profile
Education:
- Graduate: Faculty of Pharmacy, Ankara University, 1985
- Master: Faculty of Pharmacy / Pharmaceutical Technology, Gazi University, 1988
- PhD: The School of Pharmacy, University of Wales, Cardiff, UK, 1996
Professional Titles and Roles:
- Research Assistant: Gazi University, Faculty of Pharmacy, Ankara, Turkey (1985-1996)
- Dr. Research Assistant: Gazi University, Faculty of Pharmacy, Ankara, Turkey (1996-1996)
- Dr. Second Lieutenant: M.S.B. Army Drug Factory, Ankara, Turkey (1996-1998)
- Assistant Professor: Gazi University, Faculty of Pharmacy, Ankara, Turkey (1998-2004)
- Associate Professor: Gazi University, Faculty of Pharmacy, Ankara, Turkey (2004-2009)
- Professor: Gazi University, Faculty of Pharmacy, Ankara, Turkey (2009-)
- Vice Dean: Gazi University, Faculty of Pharmacy, Ankara, Turkey (2010-2012)
- Dean: Gazi University, Faculty of Pharmacy, Ankara, Turkey (2012-2016)
- Vice Dean: Biruni University, Faculty of Pharmacy, Istanbul, Turkey (2016-2019)
- Dean: Biruni University, Faculty of Pharmacy, Istanbul, Turkey (2020-)
Consultancy and Committee Memberships:
- Consultant: Health of Ministry, Drug Licensing office (1999-2019)
- Committee Member: The Scientific And Technological Research Council Of Turkey (2008-2012)
- Evaluator: Higher Education Institution of Turkey (YÖK), Quality Board (2017-)
Patents:
- Method for measuring blood urea level by reverse iontophoresis (US7231242, EP1526891, AT480296, CN100431641)
- Hemodialysis cartridge (US8057680, RU2323015, TR200401118, CN100518837)
- Extended release fluvastatin tablet (TR200800634)
- Swallable Iontophoresis tablet (TR201720318A2)
Editorial Board Memberships:
- Hacettepe University Journal of the Faculty of Pharmacy: 2006-2014
- Journal of Biophysical Chemistry: 2010-2017
- Asian Chemistry Letters: 2011-
- Türkiye klinikleri, Eczacılık Bilimleri: 2011-
- Austin Chromatography: 2014-
- ACTA Pharmaceutica Sciencia: 2017-
- Pharmaceutical Drug Regulatory Affairs Journal: 2018-
- Bırunı Health And Educatıon Scıences Journal: 2017-
- Pharmaceutical Science and Technology: 2018-
- Current Drug Delıvery: 2023-
Evaluation for the Research for Community Impact Award:
Research Contributions: Dr. Ismail Tuncer DEGIM has made significant contributions to pharmaceutical sciences, particularly in drug delivery systems and pharmaceutical technology. His research spans various innovative methods and technologies that directly impact community health.
- Patents and Innovations:
- His patents on measuring blood urea levels and hemodialysis cartridges have practical applications in improving diagnostic and treatment methods, benefiting patients with kidney issues and those requiring dialysis.
- The development of extended-release tablets and iontophoresis tablets demonstrates his work on advanced drug delivery systems, which improve patient compliance and therapeutic efficacy.
- Leadership and Mentorship:
- Dr. DEGIM has held numerous leadership positions, including Dean at multiple universities, where he has influenced the direction of pharmaceutical education and research.
- His roles in consultancy and evaluation for health and educational institutions show his commitment to improving standards and practices in pharmaceutical sciences and healthcare.
- Editorial and Scholarly Contributions:
- Serving on the editorial boards of various scientific journals, Dr. DEGIM has contributed to the dissemination and critical evaluation of pharmaceutical research, enhancing the quality and impact of published work.
Impact on Community: Dr. DEGIM’s work has a tangible impact on community health through the development of better diagnostic tools, improved drug delivery systems, and effective treatments. His research addresses critical healthcare needs, from chronic kidney disease management to innovative drug formulations, making his contributions invaluable to public health.
Conclusion: Dr. Ismail Tuncer DEGIM is a strong candidate for the Research for Community Impact Award. His extensive research portfolio, leadership in pharmaceutical education, and commitment to practical healthcare solutions demonstrate his significant contributions to improving community health and wellbeing. His innovative work and dedication to advancing pharmaceutical sciences make him an exemplary researcher deserving of recognition for his impact on the community.
Publications top noted📜
- Controlled delivery of peptides and proteins 💊
- Authors: I Tuncer Degim, N Celebi
- Journal: Current Pharmaceutical Design
- Year: 2007
- Citations: 215
- Epidermal permeability–penetrant structure relationships: 4, QSAR of permeant diffusion across human stratum corneum in terms of molecular weight, H-bonding and electronic charge 🔬
- Authors: WJ Pugh, IT Degim, J Hadgraft
- Journal: International Journal of Pharmaceutics
- Year: 2000
- Citations: 129
- New tools and approaches for predicting skin permeability 🛠️
- Authors: IT Degim
- Journal: Drug Discovery Today
- Year: 2006
- Citations: 101
- Prediction of skin penetration using artificial neural network (ANN) modeling 🤖
- Authors: T Değim, J Hadgraft, S İlbasmiş, Y Özkan
- Journal: Journal of Pharmaceutical Sciences
- Year: 2003
- Citations: 91
- Skin permeability data: anomalous results 📊
- Authors: IT Degim, WJ Pugh, J Hadgraft
- Journal: International Journal of Pharmaceutics
- Year: 1998
- Citations: 88
- Anti-aging formulation of rosmarinic acid-loaded ethosomes and liposomes 🧴
- Authors: Ç Yücel, G Şeker Karatoprak, İT Değim
- Journal: Journal of Microencapsulation
- Year: 2019
- Citations: 76
- Carbon nanotubes for transdermal drug delivery 🌐
- Authors: IT Degim, DJ Burgess, F Papadimitrakopoulos
- Journal: Journal of Microencapsulation
- Year: 2010
- Citations: 75
- Carbon nanotubes to deliver drug molecules 💊
- Authors: S Ilbasmiş-Tamer, Ş Yilmaz, E Banoğlu, IT Değim
- Journal: Journal of Biomedical Nanotechnology
- Year: 2010
- Citations: 75
- Rapid and simultaneous determination of acetylsalicylic acid, paracetamol, and their degradation and toxic impurity products by HPLC in pharmaceutical dosage forms 🧪
- Authors: C Akay, İT Değim, A Sayal, A Aydin, Y Özkan, H Gül
- Journal: Turkish Journal of Medical Sciences
- Year: 2008
- Citations: 72
- The effects of Azone and capsaicin on the permeation of naproxen through human skin 🧴
- Authors: IT Degim, A Uslu, J Hadgraft, T Atay, C Akay, S Cevheroglu
- Journal: International Journal of Pharmaceutics
- Year: 1999
- Citations: 68
- Reverse iontophoresis: a non-invasive technique for measuring blood urea level 🔬
- Authors: IT Degim, S Ilbasmis, R Dundaroz, Y Oguz
- Journal: Pediatric Nephrology
- Year: 2003
- Citations: 64
